Abstract:Background: Proline-rich transmembrane protein 2 (PRRT2) plays an important role in the central nervous system and mutations in the gene are implicated in a variety of neurological disorders. This study aimed to summarize the clinical characteristics and gene expression analysis of neurological diseases related to the PRRT2 gene and explore the clinical characteristics, therapeutic effects, and possible pathogenic mechanisms of related diseases. Methods: We enrolled 10 children with PRRT2 mutation-related neurological diseases who visited the Children's Hospital affiliated with the Shanghai Jiaotong University School of Medicine/Shanghai Children's Hospital between May 2017 and February 2022. Video electroencephalography (VEEG), cranial imaging, treatment regimens, gene results, and gene expression were analyzed. Genetic testing involved targeted sequencing or whole-exome genome sequencing (WES). We further analyzed the expression and mutation conservation of PRRT2 and synaptosome-associated protein 25 (SNAP25) in blood samples using quantitative polymerase chain reaction (qPCR) and predicted the protein structure. Summary analysis of the reported gene maps and domains was also performed. Results: Ten children with PRRT2 gene mutations were analyzed, and 4 mutations were identified, consisting of 2 new (c.518A > C, p.Glu173 Ala; c.879 + 112G > A, p.?) and two known (c. 649 dup, p. Arg217Profs * 8; c. 649 del, p. Arg217Glufs * 12) mutations. Among these mutations, one was de novo (P6), and three could not be determined because one parent refused genetic testing. The clinical phenotypes were paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), epilepsy, infantile spasms, and intellectual disability. The qPCR results showed that PRRT2 gene expression levels were significantly lower in children and parent carriers than the control group. The SNAP25 gene expression level of affected children was significantly lower ( P ≤ 0.001) than that of the control group. The mutation sites reported in this study are highly conserved in different species. Among the various drugs used, oxcarbazepine and sodium valproate were the most effective. All 10 children had a good disease prognosis, and 8 were completely controlled with no recurrence, whereas 2 had less severe and fewer seizures. Conclusion: Mutation of PRRT2 led to a significant decrease in its protein expression level and that of SNAP25, suggesting that the mutant protein may lead to the loss of its function and that of related proteins. This mutation site is highly conserved in most species, and there was no significant correlation between specific PRRT2 genotypes and clinical phenotypes. Asymptomatic carriers also have decreased gene expression levels, suggesting that more factors are involved.

Progress in Pathogenesis of Dopa-responsive Dystonia

ATP1A3 Mutation in Rapid-Onset Dystonia Parkinsonism: New Data and Genotype-Phenotype Correlation Analysis

Phenotypic Overlap among Paroxysmal Dyskinesia Subtypes: Lesson from a Family with PRRT2 Gene Mutation.

Analysis of Clinical Phenotype and CGH1 Gene Mutations in a Family Affected with Dopa-Responsive Dystonia

The Progress in the Study of the Pathogenesis of Primary Dystonia

Molecular Genetics of Dopa-Responsive Dystonia in Chinese

Molecular genetic study of Han nationality dopa-responsive dystonia in three Chinese families

[Clinical Analysis of Dopa-Responsive Dystonia and Mutation Analysis of the GCH I Gene].

A Novel Tyrosine Hydroxylase Variant in a Group of Chinese Patients with Dopa-Responsive Dystonia.

Association Between Polymorphism of Dopamine D2 Receptor Genes and Therapeutic Effect of Domperidone in Functional Dyspepsia.

Molecular analyses of GCH-1, TH and parkin genes in Chinese dopa-responsive dystonia families.

[Progress of Clinical and Genetic Research on Distal Hereditary Motor Neuropathy].

Clinical and genetic characteristics of dopamine-responsive dystonia in 3 children

Etiology and Pathophysiology of Cervical Dystonia

Advances in magnetic resonance imaging of impulsive-compulsive behavior in Parkinson′s disease

Identification of TH Variants in Chinese Dopa-Responsive Dystonia Patients and Long-Term Outcomes

Genetic analysis of dystonia-related genes in Parkinson's disease

Study of GCH1 and TH genes in Chinese patients with Parkinson's disease.

Clinical characteristics and genetics of ten Chinese children with PRRT2-associated neurological diseases

Clinical and Genetic Analysis of Eight Idiopathic Cases of Paroxysmal Dyskinesia

Progress in the study of molecular genetics of BIGH3 related corneal dystrophy